Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients

High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV

NCT00381953 ·Status: COMPLETED ·Phase: PHASE3

Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments

NCT01178749 ·Status: UNKNOWN

Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients

NCT00221624 ·Status: COMPLETED ·Phase: PHASE3

Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders

NCT00122629 ·Status: TERMINATED ·Phase: PHASE3

Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4

NCT01010646 ·Status: UNKNOWN ·Phase: PHASE2

The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C

NCT01464008 ·Status: COMPLETED

Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)

NCT01121705 ·Status: COMPLETED ·Phase: PHASE3

Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C

NCT00004804 ·Status: COMPLETED ·Phase: PHASE3

Ribavirin Dose Optimization for the Treatment of Hepatitis C

NCT01289496 ·Status: COMPLETED ·Phase: PHASE2

Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C

NCT00629824 ·Status: COMPLETED ·Phase: PHASE4

A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C

NCT00144469 ·Status: COMPLETED ·Phase: PHASE3

A Study of TMC435350 Administered With or Without Standard of Care Therapy in Participants With Genotype 1 Hepatitis C Virus Infection

NCT00561353 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

NCT01447394 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

NCT02446717 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects

NCT00142103 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection

NCT02707952 ·Status: COMPLETED ·Phase: PHASE3

Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3

NCT00143000 ·Status: COMPLETED ·Phase: PHASE4

Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C

NCT00209755 ·Status: TERMINATED ·Phase: NA

Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C

NCT00148863 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1

NCT00790673 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1)

NCT00724451 ·Status: COMPLETED

Pegintron Induction Therapy in HCV Non-Responders

NCT00363259 ·Status: COMPLETED ·Phase: PHASE3

A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection

NCT01846832 ·Status: COMPLETED ·Phase: PHASE3

High Dose Ribavirin in the Treatment of Chronic Hepatitis C

NCT00944684 ·Status: COMPLETED ·Phase: PHASE2

S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C

NCT00475176 ·Status: COMPLETED ·Phase: PHASE2